InvestorsHub Logo

dr_lowenstein

12/30/21 3:15 PM

#363910 RE: HGilS #363909

it is quite possible that nasrat is simply confused.He really doesnt know the pharma business very well

jour_trader

12/30/21 3:19 PM

#363911 RE: HGilS #363909

There was never a puzzle here. Listen to the call, Nasrat clearly says Loxapine, not Fluoxetine. It’s a typo in the script. He says Loxapine twice. There is no slip up. It’s a product that has already launched that brings in a minuscule amount of revenue.

WeeZuhl

12/30/21 3:47 PM

#363912 RE: HGilS #363909

Weezuhl. You solved the puzzle!!!

Nasrat dropped news by mistake.

He is working on Prozac generic it is the first time ever he names that molecule.

This makes sense approval in Q1 2022. Partnership with the guys who will market loxapine in June 2022